Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Filter

Your Filters

Reset filters

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Genomics of clonal evolution in a rare essential thrombocythemia with coexisting Type 2 CALR and MPL S204P mutations.

Authors : Jing Wang^1,2; Wenjing Fu²; Wenqiang Bao³

Source: Platelets. Dec2023, Vol. 34 Issue 1, p1-4. 4p.

Record details

Read Online Read More Add to Saved list

Academic Journal

CRISPR-Cas9-Mediated Cytosine Base Editing Screen for the Functional Assessment of CALR Intron Variants in Japanese Encephalitis Virus Replication.

Authors : Xiong, Youcai¹ (AUTHOR) ; Xi, Xiaoning¹ (AUTHOR) ; Xiang, Yue¹ (AUTHOR)

Source: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13331. 11p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Transcriptomic comparison of bone marrow CD34 + cells and peripheral blood neutrophils from ET patients with JAK2 or CALR mutations.

Authors : Guijarro-Hernández, Ana¹ (AUTHOR); Vizmanos, José Luis¹ (AUTHOR)

Source: BMC Genomic Data. 8/7/2023, Vol. 24 Issue 1, p1-14. 14p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Frequency of JAK2V617F, MPL and CALR driver mutations and associated clinical characteristics in a Norwegian patient cohort with myeloproliferative neoplasms.

Authors : Lilleskare, Susanne¹ (AUTHOR); Vorland, Marta² (AUTHOR); Vo, Anh Khoi³ (AUTHOR)

Source: Scandinavian Journal of Clinical & Laboratory Investigation. Feb2023, Vol. 83 Issue 1, p3-7. 5p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Genomics of clonal evolution in a rare essential thrombocythemia with coexisting Type 2 CALR and MPL S204P mutations.

Authors : Wang, Jing^1,2 (AUTHOR); Fu, Wenjing² (AUTHOR); Bao, Wenqiang³ (AUTHOR)

Source: Platelets. 2023, Vol. 34 Issue 1, p1-4. 4p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib.

Authors : Huo, Li¹ (AUTHOR); Xie, Jundan¹ (AUTHOR); Wang, Qian¹ (AUTHOR)

Source: Clinical Case Reports. Jan2023, Vol. 11 Issue 1, p1-7. 7p.

Record details

Read Online Read More Add to Saved list

Academic Journal

JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms.

Authors : Isabel Giraldo-Rincón, Ana¹; Naranjo Molina, Sara¹; Gomez-Lopera, Natalia¹

Source: Colombia Medica. 2023, Vol. 54 Issue 3, p1-12. 12p.

Record details

Read Online Read More Add to Saved list

Academic Journal

ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.

Authors : Yu, Gang¹ (AUTHOR); Gao, Juan² (AUTHOR); Hu, Weifeng³ (AUTHOR)

Source: Scientific Reports. 9/21/2023, Vol. 13 Issue 1, p1-10. 10p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients.

Authors : Elgohary, Sawsan¹ (AUTHOR) ; Eissa, Reda A.² (AUTHOR) ; El Tayebi, Hend M.¹ (AUTHOR)

Source: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 18, p14254. 31p.

Record details

Read Online Read More Add to Saved list

Academic Journal

Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR -Mutated MPN.

Authors : Wang, Ying-Hsuan¹ (AUTHOR) ; Chen, Ying-Ju¹ (AUTHOR) ; Lai, Yi-Hua¹ (AUTHOR)

Source: International Journal of Molecular Sciences. May2023, Vol. 24 Issue 10, p8747. 16p.

Record details

Read Online Read More Add to Saved list

Search Results

Your Filters

Genomics of clonal evolution in a rare essential thrombocythemia with coexisting Type 2 CALR and MPL S204P mutations.

CRISPR-Cas9-Mediated Cytosine Base Editing Screen for the Functional Assessment of CALR Intron Variants in Japanese Encephalitis Virus Replication.

Transcriptomic comparison of bone marrow CD34 + cells and peripheral blood neutrophils from ET patients with JAK2 or CALR mutations.

Frequency of JAK2V617F, MPL and CALR driver mutations and associated clinical characteristics in a Norwegian patient cohort with myeloproliferative neoplasms.

Genomics of clonal evolution in a rare essential thrombocythemia with coexisting Type 2 CALR and MPL S204P mutations.

Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib.

JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms.

ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.

Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients.

Mutation-Driven S100A8 Overexpression Confers Aberrant Phenotypes in Type 1 CALR -Mutated MPN.

Contact

Follow us